Menlo Therapeutics Inc. Contracts & Agreements

84 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
First Amendment to the VYNE Therapeutics Inc. 2023 Equity Incentive Plan
Bonus & Incentive Agreements
Menlo Therapeutics Inc.
2024
Non-Employee Director Compensation Policy
Compensation Agreements
Menlo Therapeutics Inc.
2024
Sales Agreement, dated as of
Sales Agreements
Menlo Therapeutics Inc.
2024
Form of Employee Restricted Share Unit Grant Notice and Restricted Share Unit Award Agreement under the 2023 Equity Incentive Plan
Bonus & Incentive Agreements
Menlo Therapeutics Inc.
2023
Form of Employee Option Grant Notice and Option Agreement under the 2023 Equity Incentive Plan
Bonus & Incentive Agreements
Menlo Therapeutics Inc.
2023
Form of Director Option Grant Notice and Option Agreement under the 2023 Equity Incentive Plan
Bonus & Incentive Agreements
Menlo Therapeutics Inc.
2023
VYNE Therapeutics Inc. 2023 Equity Incentive Plan
Bonus & Incentive Agreements
Menlo Therapeutics Inc.
2023
Form of Registration Rights Agreement, dated as of October 27, 2023, by and among VYNE Therapeutics Inc. and the Purchasers
Registration Rights Agreements
Menlo Therapeutics Inc.
2023
Form of Securities Purchase Agreement, dated as of October 27, 2023, by and among VYNE Therapeutics Inc. and the Purchasers
Purchase Agreements
Menlo Therapeutics Inc.
2023
Form of Pre-Funded Warrant to Purchase Common Stock
Warrant Agreements
Menlo Therapeutics Inc.
2023
License Agreement, dated as of April 28, 2023, by and between VYNE Therapeutics Inc. and Tay Therapeutics Limited
License Agreements
Menlo Therapeutics Inc.
2023
Letter Agreement, dated as of February 27, 2023, by and between VYNE Therapeutics Inc. and Tay Therapeutics Ltd
Menlo Therapeutics Inc.
2023
Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934
Menlo Therapeutics Inc.
2023
Registration Rights Agreement, dated November 11, 2022, between VYNE Therapeutics Inc. and Mutual Fund Series Trust, on behalf of Alpha
Registration Rights Agreements
Menlo Therapeutics Inc.
2022
Securities Purchase Agreement, dated November 11, 2022, between VYNE Therapeutics Inc. and Mutual Fund Series Trust, on behalf of Alpha
Purchase Agreements
Menlo Therapeutics Inc.
2022
Letter Agreement, dated as of June 15, 2022, by and between VYNE Therapeutics Inc. and In4Derm Limited
Menlo Therapeutics Inc.
2022
Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934
Menlo Therapeutics Inc.
Pharmaceuticals
2022
Offer Letter, dated as of March 15, 2022, by and between VYNE Pharmaceuticals Inc. and Tyler Zeronda
Menlo Therapeutics Inc.
2022
Offer Letter, dated as of March 7, 2022, by and between VYNE Pharmaceuticals Inc. and Iain Stuart
Menlo Therapeutics Inc.
2022
Registration Rights Agreement, dated as of March 15, 2022, by and between the Company and Lincoln Park
Registration Rights Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
NY
2022
Purchase Agreement, dated as of March 15, 2022, by and between the Company and Lincoln Park
Purchase Agreements
Menlo Therapeutics Inc.
2022
Asset Purchase Agreement, dated as of January 12, 2022, by and between VYNE Therapeutics Inc. and Journey Medical Corporation
Purchase Agreements
Menlo Therapeutics Inc.
2022
Evaluation and Option Agreement, dated as of April 30, 2021, by and between In4Derm Limited and VYNE Therapeutics Inc
Menlo Therapeutics Inc.
2021
License Agreement (Topical), dated as of August 9, 2021, by and between In4Derm Limited and VYNE Therapeutics Inc
License Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
NY
2021
Controlled Equity Offering Sales AgreementSM, dated August 12, 2021, by and between VYNE Therapeutics Inc. and Cantor Fitzgerald & Co
Sales Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
NY
2021
Offer Letter, dated as of June 7, 2021, by and between Tyler Zeronda and VYNE Pharmaceuticals Inc
Menlo Therapeutics Inc.
2021
Offer Letter, dated as of April 7, 2021, by and between Mutya Harsch and VYNE Pharmaceuticals Inc
Menlo Therapeutics Inc.
Pharmaceuticals
2021
Offer Letter, dated as of April 7, 2021, by and between Andrew Saik and VYNE Pharmaceuticals Inc
Menlo Therapeutics Inc.
2021
Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934
Menlo Therapeutics Inc.
2021
Form of Restricted Stock Unit Award Grant Notice and Restricted Stock Unit Agreement under the 2018 Equity Incentive Plan
Bonus & Incentive Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
DE
2021
Form of Securities Purchase Agreement, dated January 26, 2021, among VYNE Therapeutics Inc. and the purchasers identified therein
Purchase Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
NY
2021
Amendment No. 1 to Amended and Restated Credit Agreement and Guaranty, dated August 5, 2020, by and among Menlo Therapeutics Inc., Foamix Pharmaceuticals Ltd., Foamix...
Credit Agreements
Menlo Therapeutics Inc.
2020
License Agreement, dated as of April 21, 2020, by and between Foamix Pharmaceuticals Ltd. and Cutia Therapeutics (HK) Limited
License Agreements
Menlo Therapeutics Inc.
2020
Underwriting Agreement, dated June 4, 2020, among Menlo Therapeutics Inc., Cowen and Company, LLC and Piper Sandler & Co., as representatives of the several underwriters named in...
Underwriting Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
NY
2020
Second Amended and Restated Warrant, by and among Menlo Therapeutics Inc. and Orbimed Royalty & Credit Opportunities III, LP
Credit Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
DE
2020
Form of Share Option Grant Notice and Option Agreement under the Menlo Therapeutics Inc. 2019 Equity Incentive Plan for U.S. and Israeli Employees
Bonus & Incentive Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
2020
Menlo Therapeutics Inc. 2019 Equity Incentive Plan
Bonus & Incentive Agreements
Menlo Therapeutics Inc.
2020
Amended and Restated Security Agreement, dated as of March 9, 2020, among Foamix Pharmaceuticals Inc., Foamix Pharmaceuticals Ltd., Menlo Therapeutics Inc. and Perceptive Credit...
Credit Agreements
Menlo Therapeutics Inc.
2020
Amended and Restated Credit Agreement and Guaranty, dated as of March 9, 2020, among Foamix Pharmaceuticals Inc., Menlo Therapeutics Inc., Foamix Pharmaceuticals Ltd., the...
Credit Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
NY
2020
Second Amended and Restated Warrant, by and among Menlo Therapeutics Inc. and Perceptive Credit Holdings II, LP
Credit Agreements
Menlo Therapeutics Inc.
2020
Offer Letter, dated as of March 20, 2020, by and between Menlo Therapeutics Inc. and Andrew Saik
Menlo Therapeutics Inc.
Pharmaceuticals
NJ
2020
Offer Letter, dated as of March 25, 2020, by and between Menlo Therapeutics Inc. and David Domzalski
Menlo Therapeutics Inc.
Pharmaceuticals
NJ
2020
Menlo Therapeutics Inc. 2019 Employee Share Purchase Plan
Share Agreements
Menlo Therapeutics Inc.
2020
Form of Restricted Share Unit Grant Notice and Restricted Share Unit Award Agreement under the Menlo Therapeutics Inc. 2019 Equity Incentive Plan for U.S. and Israeli Executives
Bonus & Incentive Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
2020
Form of Share Option Grant Notice and Option Agreement under the Menlo Therapeutics Inc. 2019 Equity Incentive Plan for U.S. and Israeli Executives
Bonus & Incentive Agreements
Menlo Therapeutics Inc.
2020
Form of Restricted Share Unit Grant Notice and Restricted Share Unit Award Agreement under the Menlo Therapeutics Inc. 2019 Equity Incentive Plan for U.S. and Israeli Employees
Bonus & Incentive Agreements
Menlo Therapeutics Inc.
2020
Termination of Employment Agreement and Release, dated as of March 22, 2020, by and between Foamix Pharmaceuticals Ltd. and Ilan Hadar
Termination Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
2020
Form of Warrant, by and among Menlo Therapeutics Inc. and certain warrant holders of Foamix Pharmaceuticals Ltd
Warrant Agreements
Menlo Therapeutics Inc.
2020
Contingent Stock Rights Agreement, dated as of March 9, 2020, by and between Menlo Therapeutics Inc. and American Stock Transfer & Trust Company, LLC
Stock Agreements
Menlo Therapeutics Inc.
2020
Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934
Menlo Therapeutics Inc.
Pharmaceuticals
2020
Amendment No. 1 to the Agreement and Plan of Merger, dated as of December 4, 2019, by and among Menlo Therapeutics Inc., Giants Merger Subsidiary Ltd. and Foamix Pharmaceuticals...
Merger Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
2019
Amendment No. 1 to the Agreement and Plan of Merger, dated as of December 4, 2019, by and among Menlo Therapeutics Inc., Giants Merger Subsidiary Ltd. and Foamix Pharmaceuticals...
Merger Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
2019
Form of CSR Agreement
Menlo Therapeutics Inc.
Pharmaceuticals
DE
2019
Agreement and Plan of Merger, dated as of November 10, 2019, by and among Menlo Therapeutics Inc., Giants Merger Subsidiary Ltd. and Foamix Pharmaceuticals Ltd
Merger Agreements
Menlo Therapeutics Inc.
2019
Form of Foamix Voting Agreement, dated November 10, 2019, by and between Menlo Therapeutics Inc. and certain shareholders of Foamix Pharmaceuticals Ltd
Voting Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
DE
2019
Form of Menlo Voting Agreement, dated November 10, 2019, by and between Foamix Pharmaceuticals Ltd. and certain stockholders of Menlo Therapeutics Inc
Voting Agreements
Menlo Therapeutics Inc.
2019
Professional Services Agreement, dated June 1, 2019, by and between the Company and Mary Spellman, M.D
Services Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
CA
2019
First Amendment to Sublease, dated April 12, 2019, by and between the Company and Relypsa, Inc
Lease Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
2019
Offer Letter, by and between the Registrant and Mary Spellman, effective as of July 21, 2017
Menlo Therapeutics Inc.
Pharmaceuticals
2018
Amendment No. 1 to Offer Letter, by and between the Registrant and Mary Spellman, effective as of April 22, 2018
Menlo Therapeutics Inc.
Pharmaceuticals
2018
Amendment No. 1 to Offer Letter, by and between the Company and Steven Basta, effective as of May 3, 2018
Menlo Therapeutics Inc.
Pharmaceuticals
2018
Amendment No. 1 to Offer Letter, by and between the Company and Kristine Ball, effective as of May 3, 2018
Menlo Therapeutics Inc.
2018
Amendment No. 1 to Offer Letter, by and between the Company and Paul Kwon, effective as of May 3, 2018
Menlo Therapeutics Inc.
Pharmaceuticals
2018
Exclusive License Agreement, dated as of December 20, 2012, by and between the Company and Merck Sharp & Dohme Corp
License Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
NY
2018
License and Collaboration Agreement, dated as of August 10, 2016, by and among the Company, Torii Pharmaceutical Co. Ltd. and Japan Tobacco, Inc
Collaboration Agreements
Menlo Therapeutics Inc.
2018
Form of Underwriting Agreement
Underwriting Agreements
Menlo Therapeutics Inc.
2018
Form of Common Stock Certificate
Stock Agreements
Menlo Therapeutics Inc.
2018
2018 Employee Stock Purchase Plan
Stock Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
DE
2018
2018 Omnibus Incentive Plan
Bonus & Incentive Agreements
Menlo Therapeutics Inc.
2018
Form of Stock Option Grant Notice and Stock Option Agreement under the 2018 Omnibus Incentive Plan
Bonus & Incentive Agreements
Menlo Therapeutics Inc.
2018
Form of Stock Option Agreement under 2011 Stock Incentive Plan
Bonus & Incentive Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
CA
2017
Form of Immediately Exercisable Stock Option Agreement under 2011 Stock Incentive Plan
Bonus & Incentive Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
CA
2017
Amendment to 2011 Stock Incentive Plan
Bonus & Incentive Agreements
Menlo Therapeutics Inc.
2017
2011 Stock Incentive Plan, as amended
Bonus & Incentive Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
DE
2017
Form of Indemnification Agreement for directors and executive officers to be entered into following the offering
Indemnification Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
DE
2017
Form of Indemnification Agreement entered into between the Company and each of its directors and executive officers
Indemnification Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
DE
2017
Consulting Agreement dated as of March 8, 2016, by and between Tigercat Pharma, Inc., and David Collier
Consulting Agreements
Menlo Therapeutics Inc.
2017
Offer Letter, dated as of August 15, 2017 by and between the Company and Kristine Ball
Menlo Therapeutics Inc.
2017
Offer Letter, dated as of January 14, 2016 by and between the Company and Paul Kwon
Menlo Therapeutics Inc.
Pharmaceuticals
2017
Offer Letter, dated as of August 17, 2015 by and between the Company and Steven Basta
Menlo Therapeutics Inc.
Pharmaceuticals
2017
Sublease, dated September 19, 2017, by and between the Company and Relypsa, Inc
Lease Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
2017
License and Collaboration Agreement, dated as of August 10, 2016, by and among the Company, Torii Pharmaceutical Co. Ltd. and Japan Tobacco, Inc
Collaboration Agreements
Menlo Therapeutics Inc.
2017
Exclusive License Agreement, dated as of December 20, 2012, by and between the Company and Merck Sharp & Dohme Corp
License Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
NY
2017
Second Amended and Restated Investors Rights Agreement, dated June 28, 2017, by and among the Company and the investors listed therein
Investor Rights Agreements
Menlo Therapeutics Inc.
Pharmaceuticals
CA
2017